BlackRock’s Fibrocell Science Inc. FCSC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-8,318
| Closed | -$25K | – | 5136 |
|
|
2019
Q3 | $25K | Hold |
8,318
| – | – | ﹤0.01% | 4624 |
|
|
2019
Q2 | $16K | Hold |
8,318
| – | – | ﹤0.01% | 4717 |
|
|
2019
Q1 | $16K | Hold |
8,318
| – | – | ﹤0.01% | 4633 |
|
|
2018
Q4 | $13K | Buy |
8,318
+2
| +0% | +$4 | ﹤0.01% | 4638 |
|
|
2018
Q3 | $19K | Buy |
8,316
+1
| +0% | +$2 | ﹤0.01% | 4664 |
|
|
2018
Q2 | $23K | Sell |
8,315
-1
| -0% | -$3 | ﹤0.01% | 4662 |
|
|
2018
Q1 | $25K | Sell |
8,316
-215
| -3% | -$705 | ﹤0.01% | 4540 |
|
|
2017
Q4 | $28K | Hold |
8,531
| – | – | ﹤0.01% | 4515 |
|
|
2017
Q3 | $130K | Hold |
8,531
| – | – | ﹤0.01% | 4322 |
|
|
2017
Q2 | $171K | Sell |
8,531
-5,438
| -39% | -$67.1K | ﹤0.01% | 4293 |
|
|
2017
Q1 | $140K | Buy |
+13,969
| New | +$155K | ﹤0.01% | 4279 |
|
|
2016
Q2 | – | Sell |
-25
| Closed | -$1K | – | 3866 |
|
|
2016
Q1 | $1K | Buy |
+25
| New | +$998 | ﹤0.01% | 3603 |
|
BlackRock's FCSC Position: Q4 2019 in Review
BlackRock sold out of Fibrocell Science Inc. (FCSC) in Q4 2019, closing a stake of 8,318 shares — an estimated $25K sold.
BlackRock first reported a position in FCSC in Q1 2016 and held it in 12 quarters. The position peaked at $171K in Q2 2017. 0 funds tracked by Wall St. Rank hold FCSC as of Q4 2019.
- BlackRock reported no remaining Fibrocell Science Inc. position as of Q4 2019 after selling out during the quarter.
- BlackRock sold 8,318 Fibrocell Science Inc. shares in Q4 2019, an estimated $25K.
- BlackRock first reported a position in Fibrocell Science Inc. in Q1 2016 and held it in 12 quarters.
- BlackRock's Fibrocell Science Inc. position peaked at $171K in Q2 2017.
- 0 funds tracked by Wall St. Rank held Fibrocell Science Inc. as of Q4 2019.
Based on BlackRock's 13F filing for Q4 2019, filed 13 Feb 2020.